Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Asymptomatic Bacteriuria in Pregnancy
NCT02911662Terminated
- Sponsor
- Trinity Health
- Start
- Sep 2016
- Primary completion
- Jan 2018
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of cefalexin and nitrofurantoin in asymptomatic bacteriuria (ASB) (2 arms), sponsored by Trinity Health. Primary endpoint: Evidence that 3-day treatment is as effective as 7-day treatment of asymptomatic bacteriuria in pregnancy at 21 days. Started Sep 2016; status: terminated.
02
Drugs
cefalexinnitrofurantoin
03
Conditions
asymptomatic bacteriuria (ASB)
Beyond the preview
Go deeper on NCT02911662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02911662.